Results 1 to 10 of about 213,213 (205)
Physician trainees' decision making and information processing: choice size and Medicare Part D. [PDF]
PLoS ONE, 2013 Many patients expect their doctor to help them choose a Medicare prescription drug plan. Whether the size of the choice set affects clinicians' decision processes and strategy selection, and the quality of their choice, as it does their older patients ...
Andrew J Barnes +5 more
doaj +7 more sources
Patient-provider communication regarding drug costsin Medicare Part D beneficiaries with diabetes: a TRIAD Study [PDF]
BMC Health Services Research, 2010 Background Little is known about drug cost communications of Medicare Part D beneficiaries with chronic conditions such as diabetes. The purpose of this study is to assess Medicare Part D beneficiaries with diabetes' levels of communication with ...
Fung Vicki +9 more
doaj +4 more sources
Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database [PDF]
American Journal of Preventive CardiologyBackground: Approximately 14 million U.S. adults may benefit from treatment of hypertriglyceridemia to reduce risk of atherosclerotic cardiovascular disease (ASCVD).
Kabir Malkani +10 more
doaj +2 more sources
Pre-Medicare Eligible Individuals’ Decision-Making In Medicare Part D: An Interview Study [PDF]
INNOVATIONS in Pharmacy, 2010 ObjectivesThe objective of this study was to elicit salient beliefs among pre-Medicare eligible individuals regarding (1) the outcomes associated with enrolling in the Medicare Part D program; (2) those referents who might influence participants ...
Tao Jin, B.S. Pharm, Ph.D. Candidate +2 more
doaj +3 more sources
BMJ Open, 2021 Objective Benzodiazepines were excluded from Medicare Part D coverage since its introduction in 2006. Part D expanded coverage for benzodiazepines in 2013.
Minghui Li +3 more
doaj +1 more source
Exploratory Research in Clinical and Social Pharmacy, 2021 Background: Patient experience with community pharmacy services can be informed by human-centered design principles and approaches. Pharmacy services may benefit from detailed evaluations of consumer experience and patient-centered service design ...
Logan T. Murry +2 more
doaj +1 more source
JAMA, 2008 Medicare Part D Represents a bold experiment to publicly fund, but privately sell and administer, prescription drug insurance. Part D is only a relatively small part of the overall Medicare program; Medicare spent $432 billion overall in 2007, of which Part D accounted for only 11.6% ($50 billion).1 However, the Medicare program is so large that Part D
Dana P. Goldman, Geoffrey F. Joyce
openaire +1 more source
Cost-Savings and Patient Experience with a Pharmacy-Led Medicare Part D Consultation Service
INNOVATIONS in Pharmacy, 2020 Background: There are many Medicare Part D plans, making it difficult for patients to choose the optimal plan. The decision to remain on current Medicare plans is reinforced by patient inertia and uncertainty associated with plan-switching decisions.
Logan Murry +3 more
doaj +1 more source
Exploratory Research in Clinical and Social Pharmacy, 2023 Background: A variety of services exit to assist eligible beneficiaries select Medicare Part D insurance plans; however, selecting an optimal plan remains a challenge.
Logan T. Murry +2 more
doaj +1 more source
Pharmaceutical advertising and Medicare Part D [PDF]
Journal of Health Economics, 2013 We explore how and to what extent prescription drug insurance expansions affect incentives for pharmaceutical advertising. When insurance expansions make markets more profitable, firms respond by boosting advertising. Theory suggests this effect will be magnified in the least competitive drug classes, where firms internalize a larger share of the ...
Darius, Lakdawalla +2 more
openaire +2 more sources